In this Part 3 and last in the series of Today's Veterinary Practice articles, "Canine Pituitary Dependent Hyperadrenocorticism," current and investigative therapies are discussed. These include adrenal-directed therapy, pituitary-directed therapy and glucocorticoid re...
Organohalogen compounds such as polychlorinated biphenyls (PCBs) and polybrominated diphenyl ethers (PBDEs) are widely used in industry. Because of their persistence and high bioaccumulative potency, PCBs and PBDEs have been detected in both animal species and humans a...
This article presents Part 2 of Today’s Veterinary Practice series, “Canine Pituitary Dependent Hyperadrenocorticism.” This paper briefly describes the diagnosis of PDH, also known as Cushing’s disease, including clinical signs, common laboratory findings, and atypical...
Canine pituitary dependent hyperadrenocorticism (PDH), also known as Cushing’s disease, is a common endocrine disorder in older dogs. This disorder is caused by a pituitary adenoma (PA) that secretes inappropriate amounts of adrenocorticotropic hormone (ACTH), which re...
Today’s Veterinary Practice | Canine Pituitary Dependent Hyperadrenocorticism Series Part 3: Current & Investigative Options for Therapy
March 22, 2016
Veterinary Debt: Does it Make Financial Sense to Become a Veterinarian?
November 24, 2013
2016 AAFP Guidelines for the Management of Feline Hyperthyroidism
May 10, 2016
Our VDIC Blog
We post on our VDIC blog regularly about news and information in the world of veterinary internal medicine and endocrinology. One of our goals is bringing you content that is relevant and useful to you and your practice. We welcome your comments and ideas. Let us know the topics you would like to see covered -- we would love to hear from you!